MBX – mbx biosciences, inc. (US:NASDAQ)
Stock Stats
News
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM Exit - What's Changed [Yahoo! Finance]
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $18.00 price target on the stock.
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus [Yahoo! Finance]
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% [Yahoo! Finance]
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones [Yahoo! Finance]
Form 4 MBX Biosciences, Inc. For: Nov 22 Filed by: Hoerter Steven L.
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: Hawryluk P. Kent
Form SCHEDULE 13G/A MBX Biosciences, Inc. Filed by: Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: New Enterprise Associates 17, L.P.
Form 4 MBX Biosciences, Inc. For: Nov 06 Filed by: Hoerter Steven L.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.